WHO ICTRP trial
The Efficacy and Safety of Irreversible Electroporation for the Ablation of…
NL-OMON40514 · Overview of Medical Research in the Netherlands (NL-OMON)
Key facts
| Trial ID | NL-OMON40514 |
|---|---|
| Public title | The Efficacy and Safety of Irreversible Electroporation for the Ablation of Renal Masses: A Prospective, Human, In-Vivo Study. |
| Scientific title | The Efficacy and Safety of Irreversible Electroporation for the Ablation of Renal Masses: A Prospective, Human, In-Vivo Study. - Efficacy and Safety of IRE for RMs. |
| Primary sponsor | Academisch Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Study type | Interventional |
| Phase | 2 |
| Countries | The Netherlands |
| Conditions | renal cancer renal cell carcinoma;10038364;renal cancer;renal cell carcinoma |
| Interventions | Patients will undergo IRE ablation of a renal tumour. The IRE procedure will take place at the Intervention Radiology room at the OR complex under general anesthesia with aditional muscle relaxation. ECG monitoring and synchronization of… |
| Registration date | Apr 16, 2014 |
| Target size | 10 |
| Secondary IDs | NL44785.018.13 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: